Compare · CGNX vs TMO
CGNX vs TMO
Side-by-side comparison of Cognex Corporation (CGNX) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGNX and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $176.13B, about 16.0x CGNX ($10.99B).
- Over the past year, CGNX is up 121.5% and TMO is up 17.4% - CGNX leads by 104.1 points.
- TMO has been more active in the news (19 items in the past 4 weeks vs 7 for CGNX).
- Both have 25 recent analyst ratings on file.
- Company
- Cognex Corporation
- Thermo Fisher Scientific Inc
- Price
- $66.06-0.05%
- $473.94-1.69%
- Market cap
- $10.99B
- $176.13B
- 1M return
- +17.37%
- +2.47%
- 1Y return
- +121.47%
- +17.39%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 1989
- News (4w)
- 7
- 19
- Recent ratings
- 25
- 25
Cognex Corporation
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; Cognex Designer that allows customers to build vision applications with a graphical, flowchart-based programming environment; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; and vision sensors for vision applications, such as checking the presence and size of parts; the In-Sight product line of vision systems and sensors. In addition, the company offers ID products comprising DataMan image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. The company was founded in 1981 and is headquartered in Natick, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest CGNX
- Vice President Long Darren Marc exercised 18,673 shares at a strike of $51.99 and sold $1,343,457 worth of shares (20,252 units at $66.34), decreasing direct ownership by 28% to 3,990 units (SEC Form 4)
- Cognex upgraded by Analyst with a new price target
- SEC Form SD filed by Cognex Corporation
- Cognex to Present at the TD Cowen Technology, Media & Telecom Conference
- Cognex OneVision™ Adoption Ramps as Manufacturers Scale AI Vision Globally
- Chief Legal Officer &Secretary Fennell Mark exercised 60,010 shares at a strike of $45.33 and sold $4,349,979 worth of shares (64,873 units at $67.05), closing all direct ownership in the company (SEC Form 4)
- VP and PAO Macdonald Laura Ann exercised 137,510 shares at a strike of $48.85 and sold $9,282,195 worth of shares (139,722 units at $66.43), decreasing direct ownership by 30% to 5,258 units (SEC Form 4)
- SVP, Chief Financial Officer Fehr Dennis converted options into 5,394 shares and covered exercise/tax liability with 1,984 shares, increasing direct ownership by 27% to 15,988 units (SEC Form 4) to satisfy tax liability
- SEC Form S-8 filed by Cognex Corporation
- SEC Form 10-Q filed by Cognex Corporation
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)